CHEGAEV, Konstantin

CHEGAEV, Konstantin  

SCIENZA E TECNOLOGIA DEL FARMACO  

Mostra records
Risultati 1 - 20 di 29 (tempo di esecuzione: 0.023 secondi).
Titolo Data di pubblicazione Autore(i) File
Amphiphile NO-donor antioxidants as polivalent drugs 2006 MARINI E; LAZZARATO L; CHEGAEV K; FRUTTERO R; GASCO A
Evaluation of the targeting ability of folate containing liposomal nitrooxy-doxorubicin. 2015 Pedrini, I.; Costamagna, F.; Buondonno, I.; Salaroglio, I. C.; Rolando, B.; Chegaev, K.; Fruttero, R.; Riganti, C.; Arpicco, S.
IN VITRO CARDIOVASCULAR TOXICITY RISK ASSESSMENT OF NOVEL H2S-DONATING ANTHRACYCLINE 2017 Durante, M.; Frosini, M.; Fusi, F.; Riganti, Chiara; Gazzano, Elena; Chegaev, Konstantin; Saponara, S.
INCAPSULATED NO-GEMCITABINE: GASEOUS SOLUTION FOR MDR PANCREATIC CANCER 2019 Chegaev, K.; Masetto, F.; Gazzano, E.; Mullappily, N.; Rolando, B.; Donadelli, M.; Arpicco, S.; Riganti, C.; Fruttero, R.
MITOCHONDRIAL-TARGETING NITROOXYDOXORUBICIN: EFFECTS ON P-GLYCOPROTEIN AND ASSESSMENT OF THEIR VASCULAR EFFECTS 2014 Frosini Maria; Maestrini Vanessa; Neri Annalisa; Santulli Chiara; Brizi Claudia; Chegaev Konstantin; Riganti Chiara; Sgaragli Giampietro; Colabufo Nicola Antonio; Saponara Simona
MODIFIED DOXORUBICINS: "GASEOUS APPROACH" TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE 2016 Chegaev, K.; Rolando, B.; Gazzano, E.; Riganti, C.; Fruttero, R.
Multitarget antioxidant NO-donor organic nitrates: a novel approach to overcome nitrates tolerance 2022 Elisabetta Marini, Marta Giorgis, Barbara Rolando, Konstantin Chegaev
Multitarget drugs: NO-donor doxorubicins 2012 Chegaev K.; Riganti C.; Rolando B.; Federico A.; Fruttero R.; Gasco A.
Multitarget Drugs: No-Donor Doxorubicins 2015 Chegaev, Konstantin; Riganti, Chiara; Gazzano, Elena; Rolando, Barbara; Fruttero, Roberta; Gasco, Alberto
NITRIC OXIDE DONOR DOXORUBICINS: A USEFUL STRATEGY TO ADDRESS THE PROBLEM OF MDR IN CANCER THERAPY 2012 Rolando B.; Riganti C.; Chegaev K.; Fruttero R.; Gasco A.
Nitric oxide donor-doxorubicins as mdr reversing agents 2014 E.Gazzano; K. Chegaev; Pedrini I.; Kopecka J. Rolando B.;Fruttero ; Arpicco S.; Ghigo D. Riganti C.
Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat 2013 F. Chiazza; M. Rogazzo; E. Benetti; K. Chegaev; A. Di Stilo; R. Fruttero; J.C. Cutrin;R . Fantozzi; M. Collino
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. 2013 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
NO donor - melatonins: a new class of potential antiatherosclerosis agents 2005 CHEGAEV K; LAZZARATO L; GIORGIS M; CENA C; DI STILO A; FRUTTERO R; GASCO A; LUCINI V; PANNACI M
NO-Donor Cyanines As Potential Anti-Alzheimer Drugs 2011 Federico A.; Chegaev K.; Lazzarato L.; Marini E.; Fruttero R.; Gasco A.
NO-Donor Furoxans Containing a Sulphonamide Moiety and Related Furazans as Potent Carbonic Anhydrase Inhibitors 2010 Roberta Fruttero; Loretta Lazzarato; Konstantin Chegaev; Barbara Rolando; Donatella Boschi; Claudiu T. Supuran; Alessio Innocenti; Alberto Gasco
Novel amphiphilic nitric oxide releasing antioxidants: NMR spectroscopic study of their interaction with biomembrane models 2005 LOPEZ V; LAZZARATO L; CHEGAEV K; ROLANDO B; FRUTTERO R; GASCO A
Novel NO-donor Doxorubicins 2014 Daniela Cortese; Konstantin Chegaev; Chiara Riganti; Barbara Rolando; Roberta Fruttero; Alberto Gasco.
Novel Organic Nitrate Esters 2002 TRON G.C; DI STILO A; K. CHEGAEV; SORBA G; FRUTTERO R; GASCO A
NOVEL SEMISYNTHETIC DOXORUBICINS WITH REDUCED CARDIOTOXICITY 2013 Konstantin Chegaev; Loretta Lazzarato; Barbara Rolando; Chiara Riganti; Roberta Fruttero; Alberto Gasco